Wisniewski et al., "Alzheimer's disease and soluble A beta,"
Neurobiol. Aging, 15(2):143-52 (1994).
Wisniewski et al., "Therapeutics in Alzheimer's and Prion Diseases,"
Biochemical Society Transactions, 30(4):574-587 (2002).
Whitcomb et al., "Characterization of saturable binding sites for
circulating pancreatic polypeptide in rat brain," Am J Pysiol
Gastrointest Liver Physiol, 259:G687-G691 (1990).
Wong et al., "Neuritic Plaques and Cerebrovascular Amyloid in
Alzheimer Disease are Antigenically Related,"PNAS, 82:8729-8732
Wood et al., "Amyloid precursor protein processing and A|342 deposition in a transgenic mouse model of Alzheimer disease," PNAS, 94: 1550-1555 (1997).
Wood et al., "Prolines and amyloidogenicily in fragments of the
Alzheimer's peptide $iM" Biochemistry, 34:724-730 (1995).
Wu et al., "Expression of immunogenic epitopes of hepatitis B sur-
face antigen with hybrid fiagellin proteins by a vaccine strain of
Salmonella;'PNAS, 86:4726-4730 (1989).
Wu, et al., "Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor," J. Clin. Invest., 100:1804-1812(1997). Wyeth, Annual Review 2005: Creating Value . . . Advancing Health (Feb. 27, 2006).
Xiang et al., "Manipulation of the immune response to a plasmid
encoded viral antigen by coinoculation with plasmids expressing
cytokines," Immunity, 2(2): 129-135 Abstract (1995).
Xu et al., "Increased incidence of anti-|3-amyloid autoantibodies
secreted by Epstein-Barr virus transformed B cell lines from patients
with Alzheimer's disease," Mechanisms of Ageing and Development,
Yamaguchi et al., Diffuse plaques associated with astroglial amyloid |3 protein, possibly showing a disappearing stage of senile plaques, Acta Neuropathol, 95:217-222 (1998).
Yang et al., "Effects of Racemization on the Aggregational Properties of the Amyloid |3-Peptide in Alzheimer's Disease," abstract # 255 from American Chemical Society 214th National Meeting (1997). Yankner et al., "Neurotrophic and Neurotoxic effects of Amyloid |3 Protein: Reversal by Tachykinin Neuropeptides," Science, 250:279282 (1990).
Younkin, "Amyloid |3 vaccination: reduced plaques and improved cognition," Nature Medicine, 7:18-19 (2001). Zlokovic et al., "Clearance of amyloid |3-peptide from brain: transport or metabolism?," Nature Medicine, 6(7):718-719 (2000).
* cited by examiner